在NF2相关的脑膜瘤中,PD-L1调节瘤增殖和T细胞功能
Ying Wang1,2, Chao Zhang2, Minjun Yan2
1Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
CNS neuroscience & therapeutics
|June 3, 2024
概括
在神经纤维素瘤类型2 (NF2) 脑膜瘤中准编程死亡配体1 (PD-L1) 可以抑制瘤生长并恢复T细胞功能. 这种方法,可能与mTOR抑制剂相结合,为NF2患者提供了一个有前途的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 编程死亡连接体1 (PD-L1) 是许多癌症中的免疫逃避机制,通常与预后不佳有关.
- 抗PD-L1疗法是新兴的抗癌疗法,在各种恶性瘤中显示出持久的瘤回归.
- 这些药物可能是2型神经纤维素瘤 (NF2) 患者的新疗法选择.
研究的目的:
- 为了确定NF2相关脑膜瘤中的PD-L1表达.
- 研究PD-L1下调对瘤细胞特征和T细胞功能的影响.
- 探索调节PD-L1表达的途径,用于潜在的新NF2治疗.
主要方法:
- 在NF2脑膜瘤中进行PD-L1表达分析.
- 在NF2脑膜瘤细胞中PD-L1的体外淘汰.
- 与T细胞和siPD-L1转移的NF2细胞进行共同培养实验.
- 调查PI3K-AKT-mTOR通路和拉巴胺治疗.
- 用抗PD-L1抗体和mTOR抑制剂进行体内研究.
主要成果:
- 在NF2脑膜瘤中,PD-L1表达异质.
- 抑制PD-L1 Knockdown抑制了瘤细胞的增殖和增加了亡.
- 降低PD-L1调节部分恢复了T细胞激活 (CD69) 和细胞毒性功能.
- PI3K-AKT-mTOR通路调节PD-L1;拉巴胺抑制了PD-L1的表达.
- 联合抗PD-L1和mTOR抑制剂在体内显示出协同作用的抗瘤作用.
结论:
- 向PD-L1可以恢复瘤透的淋巴细胞功能,并诱导NF2脑膜瘤的亡.
- 了解NF2中PD-L1驱动的瘤发生,可以改进治疗方法.
- 这项研究可能会为NF2患者改善治疗策略.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
